FDA approval of female libido pill could cause women to suffer “epidemic of adverse effects”0

• News
• September 4, 2015

(NaturalNews) On August 18, the FDA approved a drug for the controversial condition of female hypoactive sexual desire disorder. The drug, flibanserin (to be marketed as Addyi), had previously been rejected twice by the agency due to low effectiveness combined with a high risk of serious side effects. The agency’s turnaround was not based on